You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tipifarnib

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Santa Rosa, Ridgewood (Tipifarnib, Osimertinib)

Recruiting
  • NSCLC
  • Santa Rosa, California
  • +1 more
Jan 11, 2023

Advanced Solid Tumor Trial in Canton, Austin, San Antonio (Tipifarnib)

Recruiting
  • Advanced Solid Tumor
  • Tipifarnib
  • Canton, Ohio
  • +2 more
Aug 19, 2022

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL) Trial (Tipifarnib)

Available
  • HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
  • Tipifarnib
  • (no location specified)
Jun 7, 2022

Urothelial Carcinoma Trial in Seoul (tipifarnib)

Active, not recruiting
  • Urothelial Carcinoma
  • tipifarnib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 6, 2022

HNSCC Trial in United States (Tipifarnib, Alpelisib)

Recruiting
  • HNSCC
  • Duarte, California
  • +10 more
Jun 30, 2022

Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Tipifarnib
  • Santiago De Compostela, A Coruña, Spain
  • +29 more
Sep 21, 2022

Leukemia, Myelomonocytic, Chronic Trial in United States (Tipifarnib)

Completed
  • Leukemia, Myelomonocytic, Chronic
  • Tipifarnib
  • Scottsdale, Arizona
  • +7 more
May 12, 2021

Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Korea, Republic of, Spain, United States (Tipifarnib)

Completed
  • Relapsed or Refractory Peripheral T-Cell Lymphoma
  • Tipifarnib
  • Palo Alto, California
  • +12 more
Apr 26, 2021

Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (tipifarnib, paclitaxel, doxorubicin)

Completed
Has Results
  • Breast Cancer
  • +5 more
  • tipifarnib
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 29, 2021

Thyroid Cancer, Squamous Cell Carcinoma Head Neck Cancer (HNSCC), HRAS Mutant Tumor Trial in Worldwide (Tipifarnib)

Completed
  • Thyroid Cancer
  • +3 more
  • Tipifarnib
  • Los Angeles, California
  • +34 more
May 12, 2021

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (gemcitabine HCl,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

Pancreatic Cancer Trial in Philadelphia (tipifarnib, radiation therapy)

Completed
  • Pancreatic Cancer
  • tipifarnib
  • radiation therapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 13, 2020

Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

Recruiting
  • Malignant Solid Neoplasm
  • +40 more
  • Biospecimen Collection
  • +6 more
  • Birmingham, Alabama
  • +172 more
Jan 27, 2023

MDS Trial in Boston, New York (Tipifarnib)

Terminated
  • Myelodysplastic Syndromes
  • Tipifarnib
  • Boston, Massachusetts
  • +1 more
Jan 30, 2020

Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Mature T-Cell and

Completed
Has Results
  • Anaplastic Large Cell Lymphoma
  • +12 more
  • Laboratory Biomarker Analysis
  • Tipifarnib
  • Iowa City, Iowa
  • +1 more
Apr 3, 2020

HRAS Gene Mutation, HNSCC Trial in Worldwide (Tipifarnib, HRAS Detection Assay)

Recruiting
  • HRAS Gene Mutation
  • HNSCC
  • Tipifarnib
  • HRAS Detection Assay
  • Los Angeles, California
  • +131 more
Feb 24, 2021

Leukemia Trial in Iowa City, Baltimore, Rochester (tipifarnib)

Completed
  • Leukemia
  • tipifarnib
  • Iowa City, Iowa
  • +2 more
Nov 5, 2019

Lung Cancer Trial in Philadelphia (carboplatin, paclitaxel, tipifarnib)

Completed
  • Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 12, 2019

Estrogen Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer Trial in Bronx (fulvestrant,

Completed
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Oct 4, 2018

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Accelerated Phase of Disease, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelogenous Leukemia, BCR-ABL1

Completed
  • Accelerated Phase of Disease
  • +6 more
  • Laboratory Biomarker Analysis
  • Tipifarnib
  • Palo Alto, California
  • +1 more
May 31, 2018

Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)

Completed
  • Solid Neoplasm
  • Erlotinib Hydrochloride
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
May 17, 2018

Brain and CNS Tumors Trial in United States (tipifarnib)

Completed
  • Brain and Central Nervous System Tumors
  • tipifarnib
  • Los Angeles, California
  • +10 more
Jun 22, 2018

Neurofibroma, Plexiform, Neurofibromatosis Type I Trial in Germany, United States (tipifarnib, )

Completed
Has Results
  • Neurofibroma, Plexiform
  • Neurofibromatosis Type I
  • tipifarnib
  • placebo
  • Birmingham, Alabama
  • +11 more
Mar 15, 2018

Advanced Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis, Sorafenib Tosylate, Tipifarnib)

Completed
  • Advanced Malignant Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 26, 2017